ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,110,000 | -52.5% | 95,613 | +0.3% | 0.01% | -50.0% |
| Q4 2015 | $10,767,000 | +3.6% | 95,309 | +8.0% | 0.02% | +4.3% |
| Q3 2015 | $10,390,000 | +65.9% | 88,269 | +9.1% | 0.02% | +76.9% |
| Q2 2015 | $6,264,000 | +33.8% | 80,900 | 0.0% | 0.01% | +44.4% |
| Q1 2015 | $4,680,000 | +79.4% | 80,900 | 0.0% | 0.01% | +80.0% |
| Q4 2014 | $2,609,000 | +31.8% | 80,900 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $1,980,000 | +21.8% | 80,900 | -11.8% | 0.00% | +33.3% |
| Q2 2014 | $1,625,000 | +0.4% | 91,700 | +13.3% | 0.00% | -25.0% |
| Q1 2014 | $1,619,000 | – | 80,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |